Research Nester assesses the growth of ASEAN & Japan digital advertising in pharma and medical equipment market which is anticipated to be on account of the growing penetration of internet in ASEAN region or Japan, further boosting the growth in social media users.

New York – October 10, 2022 - Research Nester’s recent market research analysis on “ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market: Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview of the ASEAN & Japan digital advertising in pharma and medical equipment market in terms of market segmentation by ad format, platform, end user, and by region.

Growing Penetration of Mobile Phones to Boost Growth of ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market

The ASEAN & Japan digital advertising in pharma and medical equipment market is estimated to grow on account of growing penetration of mobile phones. By 2022, there were estimated to be about 320 million smartphone users in Southeast Asia, and that number would keep increasing through 2026. Mobile advertising refers to any form of advertising that displays on mobile devices such as smartphones and tablets. To advertise on these devices, businesses could use SMS text advertisements or banner ads that are posted on mobile websites. The business could also use social media to promote its products. Hence, as a large number people use smartphones, it is now become convenient for pharmaceutical and medical equipment companies to advertise their products.

Some of the major growth factors and challenges that are associated with the growth of the ASEAN & Japan digital advertising in pharma and medical equipment market are:

Growth Drivers:

• Surge in Social Media User
• Growth in Pharma and Medical Equipment Company

Challenges:

Increased competition is expected to limit the growth of digital advertising in the market for drugs and medical supplies. Owing to the unprecedented number of businesses that have entered the digital market, both demand and brand prices have increased. Marketers need to be more savvy and clever to stand out in the digital age owing to the increasing competition. As a result, producing interesting material has become essential. But, as a result of the constant stream of digital marketing content, consumers have developed noise-cancelling abilities. As a result, it is predicted that this factor would slow market expansion.

By platform, the ASEAN and Japan market for digital advertising in pharma and medical equipment is segmented into mobile, desktop, and other platforms. Out of which, the mobile segment is anticipated to garner the highest revenue of USD 1,298.6 Million and USD 3,404.1 Million by the end of 2035. Further, in the year 2022, the segment generated revenue of USD 402.7 Million and USD 1,070.7 Million. Growing penetration of mobile phones is the major factor estimated to boost the growth of the segment.

By region, the Indonesia digital advertising in pharma and medical equipment market is anticipated to garner the highest revenue of USD 906.3 Million by the end of 2035. Further, in the year 2022, the market in this region is estimated to generate revenue of USD 277.0 Million. The growth of the market in this region is estimated to grow on account of increase in the number of internet users over time, as well as surge in number of mobile and social media users.

This report also provides the existing competitive scenario of some of the key players of the ASEAN & Japan digital advertising in pharma and medical equipment market which includes company profiling of IQVIA Inc., Dentsu, Medibrandox, Ogilvy Group, Enthof, Meson Digital Marketing Agency, Indus Net TechShu, Indegene, Mysense, and others.